Recently, several Volvo owners have reported that their nearly new vehicles—purchased less than a year ago—are experiencing frequent engine malfunctions, jokingly dubbed as ‘heart disease.’ Symptoms include sudden stalling while driving, loss of power, or difficulty starting the engine, posing serious safety risks. Despite multiple similar complaints, Volvo has not issued an official recall notice to date. Consumers are questioning whether the automaker is taking potential safety hazards seriously enough and are urging the company to investigate the root cause and initiate a recall promptly. Industry experts note that if the issue stems from a design or manufacturing defect, Volvo is legally obligated under China’s ‘Regulations on the Recall of Defective Automotive Products’ to conduct a voluntary recall. Some affected owners have already filed complaints with market regulatory authorities, hoping for an official investigation. Volvo responded by stating it is analyzing individual cases technically but has not acknowledged any systemic quality issues. This incident has reignited public concern over quality control and after-sales responsiveness among premium automotive brands.
近日，有车主反映其购买不到一年的沃尔沃准新车频繁出现发动机故障，被戏称为“心脏病”。具体表现为车辆在行驶中突然熄火、动力中断或启动困难，严重影响行车安全。尽管类似问题在多个车主中集中出现，但截至目前，沃尔沃官方尚未发布相关召回公告。消费者质疑品牌方对潜在安全隐患重视不足，呼吁厂家尽快查明原因并启动召回程序。业内人士指出，若故障确属设计或制造缺陷，依据《缺陷汽车产品召回管理条例》，企业有义务主动召回。目前，部分车主已向市场监管部门投诉，期待监管部门介入调查。沃尔沃方面回应称，正对个案进行技术分析，但未承认存在系统性质量问题。此事件再次引发公众对豪华品牌质量管控与售后响应机制的关注。
原创文章，作者：admin，如若转载，请注明出处：https://avine.cn/4851.html